Comparative outcome of triamcinolone acetonide injection between 10 mg and 20 mg in de Quervain Tenosynovitis : A randomized controlled trial

Phase 4

Recruiting

• Conditions: Triamcinolone acetonide injection in de Quervain Tenosynovitis; de Quervain Tenosynovitis, Triamcinolone acetonide injection, TA injection

• Registration Number: TCTR20240429004
• Lead Sponsor: Mahavajiralongkorn Phramongkutklao Hospital Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-29
• Last Update Posted: 19 August 2024
• Study Completion: 2025-05-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

1.Patient older than 20 years of age who have diagnosed with de Quervain tenosynovitis
2.Patient who have diagnosed with de Quervain tenosynovitis who have not previously been treated with steroid injections

Exclusion Criteria

1. Patients who had underlying inflammatory joint diseases such as rheumatoid arthritis, gouty arthritis or autoimmune disease
2. 1st CMC joint arthritis and STT joint arthritis
3. Injury to the involved wrist
4. Who had history of wrist fracture
5. Previous surgery at wrist
6. Abnormal sensation of hand
7. History of an allergy to triamcinolone acetonide or lidocaine
8.Patients who do not have a communication device that can use face-to-face calling and cannot follow up on treatment at outpatient department orthopedic division Phramongkutklao Hospital

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain at 3 week, 6 weeks, 3 months, 6 months after end of the intervention use numerical rating scale between 0 to 10 for describe pain on the radial side of the wrist,Tenderness at 3 week, 6 weeks, 3 months, 6 months after end of the intervention palpate at the first dorsal compartment,Finkelstein test at 3 week, 6 weeks, 3 months, 6 months after end of the intervention bend the thumb across the palm of hand and bend the fingers down over the thumb. then bend the wrist toward the little finger

Secondary Outcome Measures

Name	Time	Method
Complication: skin atrophy at 3 week, 6 weeks, 3 months, 6 months after end of the intervention skin at injection area atrophy,Complication: hypopigmentation at 3 week, 6 weeks, 3 months, 6 months after end of the intervention skin at injection area lose pigmentation ,Complication: radial nerve injury at 3 week, 6 weeks, 3 months, 6 months after end of the intervention abnormal sensations in the back and thumb side of the hand, or in the thumb, 2nd, and 3rd fingers,Complication: tendon rupture at 3 week, 6 weeks, 3 months, 6 months after end of the intervention can not extend or abduction of the thumb